Pharmaceutical Preparation Manufacturing

Pharmaceutical Preparation Manufacturing and FY2026 as a USAspending pair

NAICS 325412 and fiscal year 2026 meet here. $6,219,341,144.28 is the USAspending.gov obligation sum on the yearlyTrend row that carries both tags. It is not Pharmaceutical Preparation Manufacturing's nationwide all-year total of $59,825,795,303.53, not every federal dollar coded to FY2026, and not an outlay register. The packet does not split therapeutic classes, or contract from assistance. 51,311 is an industry-extract action count: modifications and repeat awards add rows across years. Unique recipients are unpublished. This cell is not a lot-release log, a named-manufacturer roster, or a formulary catalog.

This page reports pharmaceutical preparation manufacturing activity USAspending tagged to FY2026. The headline $6,219,341,144.28 sits beside an industry-wide obligation total of $59,825,795,303.53; the 10.4% share is arithmetic on those two packet facts, not a ranking of fiscal years as winners or losers. Obligations are not outlays. Lot numbers, NDCs, and manufacturer names are unpublished. Quote NAICS 325412 and FY2026 together.

How USAspending labels Pharmaceutical Preparation Manufacturing in FY2026

USAspending labels NAICS 325412 as Pharmaceutical Preparation Manufacturing. That code produced $6,219,341,144.28 when crossed with fiscal year 2026. The industry-wide 325412 hub does not require a FY2026 filter. The year hub does not require Pharma Prep Mfg. Only this tie applies both filters. The packet does not split therapeutic classes, or contract from assistance. Do not forecast a full FY2026 pharma book from this snapshot. The packet has no remaining-year estimate.

Correlation is not causation: FY2026 did not cause $6,219,341,144.28 by existing as a large or small budget year. The join is 325412 × FY2026 only. This cell is not a lot-release log, a named-manufacturer roster, or a formulary catalog. Do not invent contractors or award recipients to fill the gap. Campaign donations on FEC tables do not fund this USAspending cell; the datasets are separate. Fifty-one thousand three hundred eleven industry-extract awards make 325412 a mass-action parent. Do not divide the FY2026 dollar cell by that count.

Questions

How much Pharma Prep Mfg spending is obligated in FY2026?

USAspending.gov lists $6,219,341,144.28 in Pharmaceutical Preparation Manufacturing (NAICS 325412) obligations for FY2026. That yearlyTrend amount is 10.4% of the industry's $59,825,795,303.53 extract-wide total. It is an obligation join, not an outlay and not every federal dollar in FY2026. Unique recipients are unpublished.

Is $6,219,341,144.28 the entire Pharma Prep Mfg USAspending total?

No. NAICS 325412's extract-wide total is $59,825,795,303.53. FY2026 is 10.4% of that book. Other fiscal-year rows for the same industry are separate cells. Do not add /industries/325412/ into this join. 51,311 award records stay on the industry extract, not on this yearlyTrend row.

Is $6,219,341,144.28 cash already paid in FY2026?

No. Obligations are commitments recorded on USAspending.gov awards. Outlays — money that actually left the Treasury — are a different concept and are not this packet's headline. Treating $6,219,341,144.28 as checks already cleared in FY2026 confuses those terms. Prefer the live industry and year hubs if the tables moved.

Is $6,219,341,144.28 the nationwide Pharma Prep Mfg total?

No. $6,219,341,144.28 is the FY2026 yearlyTrend slice of NAICS 325412 only. Industry-wide Pharma Prep Mfg is $59,825,795,303.53 on /industries/325412/ without this year filter. 10.4% describes this join. Outlays are unpublished. Source is USAspending.gov. USAspending.gov remains the source for NAICS 325412 in FY2026.